Few things will cause dividend investors to immediately sell a stock, but a dividend cut is one of them. So when pharmaceutical behemoth Pfizer [[PFE]] recently announced that it was halving its annual dividend to $0.64 to help finance its acquisition of Wyeth [[WYE]], the stock was unceremoniously booted from thousands of dividend-focused portfolios – [...]
According to a recent article in The New York Times, the inflation-adjusted S&P 500 has never seen a 10-year period as bad as the one that ended last month. Even after reinvesting the dividends, S&P 500 investors would have ended up losing about 5.1% a year – worse than the 4.3% compounded annual loss in [...]
A couple of years ago analysts were falling all over themselves recommending General Electric [[GE]] – the quintessential ultra-conservative blue-chip dividend payer. I recall one money manager on Consuelo Mack WealthTrack recommending it as the “one investment” that everyone should have in their portfolio, with words to the effect that it was a great buy [...]
Procter & Gamble [[PG]], like Johnson & Johnson [[JNJ]], is another one of those ultra-safe blue-chip dividend-paying stocks that has so far significantly outperformed the market during the recent turmoil when nothing’s seemed safe. It’s a regular on many lists of dividend stock recommendations, for good reason, and I’d love to own it too – [...]
If there’s one stock that seems to be on just about everyone’s list of recommended dividend stocks it’s Johnson & Johnson [[JNJ]]. It’s not hard to understand why – it’s a great company with consistent earnings and dividend growth, and the stock so far has significantly outperformed during what has been for most stocks a [...]
